249 related articles for article (PubMed ID: 37599803)
41. Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.
Balke I; Zeltins A
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121192
[TBL] [Abstract][Full Text] [Related]
42. Vaccine process technology.
Josefsberg JO; Buckland B
Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
[TBL] [Abstract][Full Text] [Related]
43. The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.
Khalid K; Poh CL
Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515079
[TBL] [Abstract][Full Text] [Related]
44. Emerging viruses and current strategies for vaccine intervention.
Afrough B; Dowall S; Hewson R
Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
[TBL] [Abstract][Full Text] [Related]
45. Applications of platform technologies in veterinary vaccinology and the benefits for one health.
Entrican G; Francis MJ
Vaccine; 2022 May; 40(20):2833-2840. PubMed ID: 35382957
[TBL] [Abstract][Full Text] [Related]
46. Current status of virus-vectored vaccines against pathogens that affect poultry.
Romanutti C; Keller L; Zanetti FA
Vaccine; 2020 Oct; 38(45):6990-7001. PubMed ID: 32951939
[TBL] [Abstract][Full Text] [Related]
47. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
[TBL] [Abstract][Full Text] [Related]
48. New approaches to the development of virus vaccines for veterinary use.
Yamanouchi K; Barrett T; Kai C
Rev Sci Tech; 1998 Dec; 17(3):641-53. PubMed ID: 9850535
[TBL] [Abstract][Full Text] [Related]
49. A Perspective on Current Flavivirus Vaccine Development: A Brief Review.
Dutta SK; Langenburg T
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112840
[TBL] [Abstract][Full Text] [Related]
50. Vaccines and vaccine resistance: Past, present and future.
Khardori N
Indian J Med Microbiol; 2022; 40(2):187-192. PubMed ID: 34961641
[TBL] [Abstract][Full Text] [Related]
51. Recombinant viral-vectored vaccines for the control of avian influenza in poultry.
Suarez DL; Pantin-Jackwood MJ
Vet Microbiol; 2017 Jul; 206():144-151. PubMed ID: 27916319
[TBL] [Abstract][Full Text] [Related]
52. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
53. Viral vectors for veterinary vaccines.
Sheppard M
Adv Vet Med; 1999; 41():145-61. PubMed ID: 9890015
[TBL] [Abstract][Full Text] [Related]
54. Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases.
Barrett PN; Terpening SJ; Snow D; Cobb RR; Kistner O
Expert Rev Vaccines; 2017 Sep; 16(9):883-894. PubMed ID: 28724343
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.
Chattopadhyay S; Chen JY; Chen HW; Hu CJ
Nanotheranostics; 2017; 1(3):244-260. PubMed ID: 29071191
[TBL] [Abstract][Full Text] [Related]
56. Measles-derived vaccines to prevent emerging viral diseases.
Frantz PN; Teeravechyan S; Tangy F
Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
[TBL] [Abstract][Full Text] [Related]
57. Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.
Papukashvili D; Rcheulishvili N; Liu C; Wang X; He Y; Wang PG
Front Immunol; 2022; 13():1050309. PubMed ID: 36389680
[TBL] [Abstract][Full Text] [Related]
58. Use of plant viruses and virus-like particles for the creation of novel vaccines.
Balke I; Zeltins A
Adv Drug Deliv Rev; 2019 May; 145():119-129. PubMed ID: 30172923
[TBL] [Abstract][Full Text] [Related]
59. DNA vaccines: a review.
Lewis PJ; Babiuk LA
Adv Virus Res; 1999; 54():129-88. PubMed ID: 10547676
[TBL] [Abstract][Full Text] [Related]
60. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
